000			02049 a2200613 4500
005			20250513220553.0
264		0	_c20001012
008			200010s 0 0 eng d
022			_a0085-2538
024	7		_a10.1046/j.1523-1755.2000.00267.x _2doi
040			_aNLM _beng _cNLM
100	1		_aKhong, T F
245	0	0	_aInhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis. _h[electronic resource]
260			_bKidney international _cSep 2000
300			_a1098-107 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a3T3 Cells
650	0	4	_aActins _xmetabolism
650	0	4	_aAlbuminuria _xchemically induced
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antineoplastic
650	0	4	_aAntibodies, Monoclonal _xanalysis
650	0	4	_aAntibody Specificity
650	0	4	_aCHO Cells
650	0	4	_aCOS Cells
650	0	4	_aCell Adhesion _ximmunology
650	0	4	_aCricetinae
650	0	4	_aEpidermal Growth Factor _xantagonists & inhibitors
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aGlomerular Filtration Rate
650	0	4	_aHeparin-binding EGF-like Growth Factor
650	0	4	_aHumans
650	0	4	_aIntegrin alpha3beta1
650	0	4	_aIntegrins _xmetabolism
650	0	4	_aIntercellular Signaling Peptides and Proteins
650	0	4	_aKidney _xcytology
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMicroscopy, Confocal
650	0	4	_aMicroscopy, Electron
650	0	4	_aNephrosis _xchemically induced
650	0	4	_aNeutralization Tests
650	0	4	_aPuromycin Aminonucleoside
650	0	4	_aRats
650	0	4	_aTransfection
700	1		_aFraser, S
700	1		_aKaterelos, M
700	1		_aPaizis, K
700	1		_aHill, P A
700	1		_aPower, D A
773	0		_tKidney international _gvol. 58 _gno. 3 _gp. 1098-107
856	4	0	_uhttps://doi.org/10.1046/j.1523-1755.2000.00267.x _zAvailable from publisher's website
999			_c10920115 _d10920115